Robeco Institutional Asset Management B.V. Sarepta Therapeutics, Inc. Transaction History

Robeco Institutional Asset Management B.V.

$51.9 Billion
Q4 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$117.53 - $155.99 $308,398 - $409,317	2,624 New	2,624 $361,000
Q2 2021 Jul 28, 2021	SELL	$69.38 - $86.75 $141,604 - $177,056	-2,041 Closed	0 $0
Q1 2021 Dec 01, 2022	BUY	$72.25 - $168.95 $147,462 - $344,826	2,041 New	2,041 $152,000
Q4 2020 Dec 01, 2022	BUY	$125.56 - $178.74 $256,267 - $364,808	2,041 New	2,041 $348,000
Q4 2020 Jan 28, 2021	SELL	$125.56 - $178.74 $172,519 - $245,588	-1,374 Reduced 40.23%	2,041 $348,000
Q3 2020 Oct 29, 2020	SELL	$127.12 - $172.34 $875,856 - $1.19 Million	-6,890 Reduced 66.86%	3,415 $479,000
Q2 2020 Jul 20, 2020	BUY	$93.0 - $171.7 $958,365 - $1.77 Million	10,305 New	10,305 $1.65 Million

Others Institutions Holding SRPT

# of Institutions

536

Shares Held

87.4M

Call Options Held

1.55M

Put Options Held

1.35M

Black Rock Inc. New York, NY

10.3M
Shares

$1.03 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

9.09M
Shares

$906 Million
0.02% of portfolio
Capital International Investors Los Angeles, CA

8.7M
Shares

$867 Million
0.21% of portfolio
Janus Henderson Group PLC London, X0

4.33M
Shares

$431 Million
0.28% of portfolio
State Street Corp Boston, MA

4.07M
Shares

$406 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $8.73B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account